Day: January 9, 2023

Promoters Cancel Australian Tour for Norwegian Black Metal Band and Alleged Neo-Nazis Taake

Australian promoters have cancelled a tour by Norwegian black metal band Taake after public pressure over the band’s alleged connections with Neo-Nazism. In a short statement released on Facebook a few days ago, promotion group Southern Extremities confirmed the tour was cancelled “for reasons beyond our control”. “Apologies to ticket holders/people keen to see these […]

SK Biopharmaceuticals to Present Future Plan for Global Investors, Partners at ‘SK Bio Night’

SK Inc.’s 1st SK Bio Night on the sidelines of J.P. Morgan Healthcare Conference offers a glimpse into the future of its global business in new drug, CDMO, biotech SK Biopharmaceuticals joins SK Inc.’s Bio Investment Center, SK pharmteco, or ‘SK bio family,’ for potential investment, partnerships SK Biopharmaceuticals CEO Donghoon Lee to present ‘next […]

Greenland Technologies Receives Nasdaq Notice on 2022 Annual General Meeting Requirement

Greenland to Hold its 2022 Annual General Meeting of Shareholders on Tuesday, January 31, 2023 EAST WINDSOR, N.J., Jan. 10, 2023 /PRNewswire/ — Greenland Technologies Holding Corporation (NASDAQ: GTEC) (“Greenland” or the “Company”) today announced that on January 4, 2023, it received a notification (the “Notification”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company […]

Insilico Medicine Announces Positive Topline Results of the New Zealand Phase I Trial of INS018_055, an AI-Designed Drug for an AI-Discovered Target

NEW YORK and HONG KONG, Jan. 10, 2023 /PRNewswire/ — Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug R&D company, today announces positive topline results of safety, tolerability, and pharmacokinetics (PK) from the Phase I clinical trial of INS018_055, a potential first-in-class drug discovered by Insilico’s end-to-end AI platform for idiopathic pulmonary fibrosis (IPF). […]

Back To Top